Treeway is pleased to announce a collaboration with the Cedars-‐Sinai Board of Governors Regenerative Medicine Institute for the development of AAV5-‐GDNF (TW002) gene therapy for ALS. Read more here.…
"The NFL has had 1000s of game changers, ALS only needs 1." Watch here.…
Bedlack founded and directs Duke University’s ALS Clinic, which takes an unusual interdisciplinary approach to helping ease the suffering and extend the lives of patients with this fatal disease. Read more here.…
(November 9, 2015) This is an Open-Label, Proof-of-Mechanism, Phase 2a trial of ibudilast in ALS patients. Read more here.…
Multi-year study of patients seeks biomarkers that can provide early detection and progression of Lou Gehrig's disease. Read more here.…
The study was designed to evaluate the safety and efficacy of transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors. Read more here.…
Scientists know that in people with some forms of amyotrophic lateral sclerosis, the motor cortex springs into action more often than it should. Now researchers conclude that the same occurs in people with ALS due to the C9ORF72 expansion. Read more here.…
Today, the launch of an Amyotrophic Lateral Sclerosis research project of Answer ALS, the largest single coordinated and comprehensive effort to end ALS, was announced. Read more here.…
Parsons, 49, has successfully lobbied for rights of families of terminally ill patients. Read more here.…
MediciNova amended the protocol to expand its recruitment to include advanced ALS patients in the trial, and this amendment was approved by FDA. Read more here.…
